Sort
30,917 grants matching “tumor microenvironment”
Lymph Node Structure and Function in Tolerance: Role of Laminins
$383,750Jonathan S Bromberg · University Of Maryland Baltimore · R01 · FY2016 · AI
Imaging the stem cell niche in regeneration and cancer
$383,625Tannishtha Reya · University Of California, San Diego · R01 · FY2012 · HL
Mechanisms of neuroinflammation in brain metastasis progression
$383,621Siyuan Zhang · University Of Notre Dame · R01 · FY2018 · CA
Targeting antigen presentation to improve immunotherapy responses in breast cancer
$383,600Justin M Balko · Vanderbilt University Medical Center · P50 · FY2021 · CA
Delineating the contribution of muscle wasting to tumor progression
$383,570Jason Doles · Indiana University Indianapolis · R21 · FY2023 · AR
Training Program in Basic and Translational Oncology
$383,491Susan E Waltz · University Of Cincinnati · T32 · FY2025 · CA
Investigating the IL-1R Pathway in Anaplastic Large Cell Lymphoma for Targeted Therapy
$383,481Yibin Yang · Research Inst Of Fox Chase Can Ctr · R01 · FY2024 · CA
Innate Immune Therapy for B-Cell Malignancies
$383,456John C Byrd · Ohio State University · P01 · FY2012 · CA
The retinal microenvironment in diabetic retinopathy
$383,444Robert A Linsenmeier · Northwestern University · R01 · FY2011 · EY
Mitochondrial DNA Mutations in Prostate Tumorigenesis and Stromal-Epithelial Inte
$383,422John A. Petros · Cedars-Sinai Medical Center · P01 · FY2011 · CA
Project 3. Overcoming Melanoma Treatment Resistance with Cytokine Immunotherapy
$383,419Aaron Michael Ring · Yale University · P50 · FY2023 · CA
Functional Analysis of p53 Polymorphic Variants
$383,402Maureen E Murphy · Wistar Institute · R01 · FY2022 · CA
Evaluation of the Efficacy of Trametinib + Navitoclax in recurrent ovarian carcinoma
$383,397Ursula Anne Matulonis · Dana-Farber Cancer Inst · P50 · FY2023 · CA
Enhanced Immunity Inside of Tumor Microenvironment
$383,381Yang-Xin Fu · University Of Chicago · R01 · FY2009 · CA
TGF&, PI3K and HER2 Pathways in Breast Cancer Metastasis
$383,371Joan Massague · Sloan-Kettering Inst Can Research · P01 · FY2017 · CA
Therapeutically Targeting Plasmacytoid Dendritic Cells in Multiple Myeloma
$383,310Kenneth C Anderson · Dana-Farber Cancer Inst · R01 · FY2019 · CA
Integration of neo-antigen vaccines and immune checkpoint therapy
$383,285Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2023 · CA
Targeting Plasmacytoid Dendritic Cells to Treat Human Myeloma
$383,275Qing Yi · Cleveland Clinic Lerner Com-Cwru · R01 · FY2014 · CA
Regulation of stem-like CD8+ T cells and their role in immunotherapy
$383,223Ana C Anderson · Brigham And Women'S Hospital · R01 · FY2024 · CA
Use of Organotypic and Mammary Gland Models to Investigate the Outcomes of Clonal
$383,164Joan Siefert Brugge · Whitehead Institute For Biomedical Res · P01 · FY2010 · CA
Understanding the role and clinical potential of dominant immune suppressive myeloid-cell responses in human cancer
$383,156Kurt A Schalper · Yale University · R01 · FY2021 · CA
Understanding the role and clinical potential of dominant immune suppressive myeloid-cell responses in human cancer
$383,156Kurt A Schalper · Yale University · R01 · FY2025 · CA
Uncovering the heterogenous role of senescence in prostate immune suppression and tumorigenesis
$383,156Marcus A. Ruscetti · Univ Of Massachusetts Med Sch Worcester · R37 · FY2024 · CA
T cell plasticity, fusion proteins and CAR T cell-based immunotherapy of head and neck cancer
$383,100Xinhui Wang · Massachusetts General Hospital · R01 · FY2022 · DE
Project 1:Evolutionary dynamics and drivers of breast cancer metastasis and relapse
$383,098Christina N Curtis · Stanford University · U54 · FY2023 · CA